Literature DB >> 7625474

Further evidence of a dose-response threshold for haloperidol in psychosis.

C K Stone1, D L Garve, J Griffith, J Hirschowitz, J Bennett.   

Abstract

OBJECTIVE: The authors' goal was to determine whether higher doses of haloperidol improve antipsychotic response.
METHOD: During a 2-week, double-blind, randomized fixed-dose study, 24 psychotic patients were given 4, 10, or 40 mg/day of haloperidol.
RESULTS: No clinically relevant difference between groups in favor of the higher antipsychotic doses could be detected.
CONCLUSIONS: Doses of 4 mg/day of haloperidol appear to be as effective as higher doses in the treatment of psychosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625474     DOI: 10.1176/ajp.152.8.1210

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  8 in total

Review 1.  Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.

Authors:  E Stip
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

Review 2.  Understanding antipsychotic "atypicality": a clinical and pharmacological moving target.

Authors:  Gary Remington
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

Review 3.  Dose response and atypical antipsychotics in schizophrenia.

Authors:  Bruce J Kinon; Jonna Ahl; Virginia L Stauffer; Angela L Hill; Peter F Buckley
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  5-HT2 antagonism and EPS benefits: is there a causal connection?

Authors:  S Kapur
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

Review 5.  Functional imaging of the brain in the evaluation of drug response and its application to the study of aging.

Authors:  C A Bryant; S H Jackson
Journal:  Drugs Aging       Date:  1998-09       Impact factor: 3.923

6.  Evaluation of Defined Daily Dose, percentage of British National Formulary maximum and chlorpromazine equivalents in antipsychotic drug utilization.

Authors:  Waleed M Sweileh; Jihad Bani Odeh; Naser Y Shraim; Sa'ed H Zyoud; Ansam F Sawalha; Samah W Al-Jabi
Journal:  Saudi Pharm J       Date:  2013-04-06       Impact factor: 4.330

Review 7.  Conventional versus novel antipsychotics: changing concepts and clinical implications.

Authors:  G Remington; S A Chong
Journal:  J Psychiatry Neurosci       Date:  1999-11       Impact factor: 6.186

8.  Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns.

Authors:  Rogelio Apiquian; Ana Fresán; Camilo de la Fuente-Sandoval; Rosa-Elena Ulloa; Humberto Nicolini
Journal:  BMC Psychiatry       Date:  2004-04-27       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.